Merja H. Voutilainen

Author

Also Known As

M. H. Voutilainen, M.H. Voutilainen, Merja H Voutilainen, Merja H. Voutilainen, Merja Voutilainen, Voutilainen, Merja H.

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Biocenter Finland Helsinki Institute of Physics National Institute on Drug Abuse University of Tartu

About

Merja H. Voutilainen is an author at University of Helsinki specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.7K
2	Social Sciences	8	8	1.2K
3	Cell Biology	3	3	593
4	Engineering	1	1	37
5	Biomedical Engineering	1	1	37

Merja H. Voutilainen

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Development and plasticity of meningeal lymphatic vessels Salli Antila, Sinem Karaman, Harri Nurmi, The Journal of Experimental Medicine MechanobiologyDevelopmental BiologyAngiogenesisOphthalmologyTumor Innervation	2017	451
Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo Päivi Lindholm, Merja H. Voutilainen, Juha Laurén, Nature Neurodegenerative DiseasesMolecular NeuroscienceNeuroprotectionNeuroscienceCell Biology	2007	437
Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease Merja H. Voutilainen, Susanne Bäck, Eeva Pörsti, Journal of Neuroscience Rat ModelSocial SciencesNeuroinflammationNeurobiology Of DiseaseNeurology	2009	267
Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease Merja H. Voutilainen, Susanne Bäck, Johan Peränen, Experimental Neurology NeurophysiologyMedicinePharmacologyNeuropharmacologyNeuroprotection	2010	136
CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice Mikko Airavaara, Brandon K. Harvey, Merja H. Voutilainen, Cell Transplantation NeurotransmitterMptp TreatmentNigrostriatal Dopamine SystemSocial SciencesPromotes Recovery	2011	132
Gene therapy with <scp>AAV</scp>2‐<scp>CDNF</scp> provides functional benefits in a rat model of <scp>P</scp>arkinson's disease Susanne Bäck, Johan Peränen, Emilia Galli, Brain and Behavior In Vivo Gene TherapyAav2 VectorsImmunologyTherapeuticsRat Model	2013	92
Netrin‐1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson’s disease features Mélissa Jasmin, Eun Hee Ahn, Merja H. Voutilainen, The EMBO Journal	2020	73
Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra Rasajna Nadella, Merja H. Voutilainen, Märt Saarma, Journal of Neuroinflammation	2014	70
Implementation of deep neural networks to count dopamine neurons in substantia nigra Anna‐Maija Penttinen, Ilmari Parkkinen, Sami Blom, European Journal of Neuroscience	2018	66
MANF regulates neuronal survival and UPR through its ER-located receptor IRE1α Vera Kovaleva, Li-Ying Yu, Larisa Ivanova, Cell Reports Cell DeathEr-located Receptor Ire1αDopamine NeuronsCellular NeurobiologySynaptic Signaling	2023	64

Page 1